Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

  • Quoted phrase not found.
1.

Distinct Muscle Biopsy Findings in Genetically Defined Adult-Onset Motor Neuron Disorders.

Jokela M, Huovinen S, Raheem O, Lindfors M, Palmio J, Penttilä S, Udd B.

PLoS One. 2016 Mar 21;11(3):e0151376. doi: 10.1371/journal.pone.0151376. eCollection 2016.

2.

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort.

Van Mossevelde S, van der Zee J, Gijselinck I, Engelborghs S, Sieben A, Van Langenhove T, De Bleecker J, Baets J, Vandenbulcke M, Van Laere K, Ceyssens S, Van den Broeck M, Peeters K, Mattheijssens M, Cras P, Vandenberghe R, De Jonghe P, Martin JJ, De Deyn PP, Cruts M, Van Broeckhoven C; Belgian Neurology consortium.

Brain. 2016 Feb;139(Pt 2):452-67. doi: 10.1093/brain/awv358. Epub 2015 Dec 15.

3.

Utility of Paraneoplastic Antibody Testing in the Diagnosis of Motor Neuron Disease.

Al-Bustani N, Simonson W, Marshall DA, Vetrovs J, Wener MH, Weiss MD, Wang LH.

J Clin Neuromuscul Dis. 2015 Dec;17(2):63-8. doi: 10.1097/CND.0000000000000080.

PMID:
26583492
4.

Tongue thickness evaluation using ultrasonography can predict swallowing function in amyotrophic lateral sclerosis patients.

Nakamori M, Hosomi N, Takaki S, Oda M, Hiraoka A, Yoshikawa M, Matsushima H, Ochi K, Tsuga K, Maruyama H, Izumi Y, Matsumoto M.

Clin Neurophysiol. 2016 Feb;127(2):1669-74. doi: 10.1016/j.clinph.2015.07.032. Epub 2015 Aug 21.

PMID:
26323377
5.

A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies.

DeLoach A, Cozart M, Kiaei A, Kiaei M.

Expert Opin Drug Discov. 2015 Oct;10(10):1099-118. doi: 10.1517/17460441.2015.1067197. Epub 2015 Aug 26. Review.

PMID:
26307158
6.

Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.

Kioumourtzoglou MA, Rotem RS, Seals RM, Gredal O, Hansen J, Weisskopf MG.

JAMA Neurol. 2015 Aug;72(8):905-11. doi: 10.1001/jamaneurol.2015.0910.

7.

Detection of TDP-43 oligomers in frontotemporal lobar degeneration-TDP.

Kao PF, Chen YR, Liu XB, DeCarli C, Seeley WW, Jin LW.

Ann Neurol. 2015 Aug;78(2):211-21. doi: 10.1002/ana.24431. Epub 2015 Jun 30.

8.

Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?

Nicholson KA, Cudkowicz ME, Berry JD.

Neurotherapeutics. 2015 Apr;12(2):376-83. doi: 10.1007/s13311-015-0341-2. Review.

9.

Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.

Wolf HH, Posa A, Panitz S, Kornhuber M, Hanisch F.

Acta Neurol Scand. 2015 Sep;132(3):212-5. doi: 10.1111/ane.12377. Epub 2015 Feb 3.

PMID:
25644365
10.

Characteristics of pain in amyotrophic lateral sclerosis.

Hanisch F, Skudlarek A, Berndt J, Kornhuber ME.

Brain Behav. 2015 Mar;5(3):e00296. doi: 10.1002/brb3.296. Epub 2015 Jan 21.

11.

Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.

Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, Heverin M, Howard RS, Huisman MH, Keren N, Leigh PN, Mazzini L, Mora G, Orrell RW, Rooney J, Scott KM, Scotton WJ, Seelen M, Shaw CE, Sidle KS, Swingler R, Tsuda M, Veldink JH, Visser AE, van den Berg LH, Pearce N.

Lancet Neurol. 2014 Nov;13(11):1108-13. doi: 10.1016/S1474-4422(14)70219-4. Epub 2014 Oct 7.

12.

Copper-based pulsed dipolar ESR spectroscopy as a probe of protein conformation linked to disease states.

Merz GE, Borbat PP, Pratt AJ, Getzoff ED, Freed JH, Crane BR.

Biophys J. 2014 Oct 7;107(7):1669-74. doi: 10.1016/j.bpj.2014.07.068.

13.

A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.

Dickens AM, Larkin JR, Griffin JL, Cavey A, Matthews L, Turner MR, Wilcock GK, Davis BG, Claridge TD, Palace J, Anthony DC, Sibson NR.

Neurology. 2014 Oct 21;83(17):1492-9. doi: 10.1212/WNL.0000000000000905. Epub 2014 Sep 24.

14.

Regulatory cascade of neuronal loss and glucose metabolism.

Hassan M, Sehgal SA, Rashid S.

CNS Neurol Disord Drug Targets. 2014;13(7):1232-45. Review.

PMID:
25230224
15.

Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain.

Slavik R, Bieri D, Cermak S, Müller A, Krämer SD, Weber M, Schibli R, Ametamey SM, Mu L.

Chimia (Aarau). 2014;68(4):208-10. doi: 10.2533/chimia.2014.208.

PMID:
24983598
16.

Characteristics and surgical results of the distal type of cervical spondylotic amyotrophy.

Tauchi R, Imagama S, Inoh H, Yukawa Y, Kanemura T, Sato K, Sakai Y, Kamiya M, Yoshihara H, Ito Z, Ando K, Muramoto A, Matsui H, Matsumoto T, Ukai J, Kobayashi K, Shinjo R, Nakashima H, Morozumi M, Ishiguro N.

J Neurosurg Spine. 2014 Sep;21(3):411-6. doi: 10.3171/2014.4.SPINE13681. Epub 2014 Jun 13.

PMID:
24926935
17.

TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis.

Cady J, Koval ED, Benitez BA, Zaidman C, Jockel-Balsarotti J, Allred P, Baloh RH, Ravits J, Simpson E, Appel SH, Pestronk A, Goate AM, Miller TM, Cruchaga C, Harms MB.

JAMA Neurol. 2014 Apr;71(4):449-53. doi: 10.1001/jamaneurol.2013.6237.

18.

Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations.

Oh SI, Park A, Kim HJ, Oh KW, Choi H, Kwon MJ, Ki CS, Kim HT, Kim SH.

PLoS One. 2014 Feb 3;9(2):e87163. doi: 10.1371/journal.pone.0087163. eCollection 2014.

19.

Multiple kernel learning captures a systems-level functional connectivity biomarker signature in amyotrophic lateral sclerosis.

Fekete T, Zach N, Mujica-Parodi LR, Turner MR.

PLoS One. 2013 Dec 31;8(12):e85190. doi: 10.1371/journal.pone.0085190. eCollection 2013.

20.

Bent spine syndrome as an early manifestation of myotonic dystrophy type 1.

Lawson VH, King WM, Arnold WD.

J Clin Neuromuscul Dis. 2013 Dec;15(2):58-62. doi: 10.1097/CND.0b013e3182a3012d.

PMID:
24263032
Items per page

Supplemental Content

Loading ...
Write to the Help Desk